Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Additional Paid-in Capital	Common Stock and Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Noncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2020		170.2
Balance at beginning of period at Dec. 31, 2020		$ 761.0		$ (2,446.0)	$ 1,127.0		$ 17.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	$ 245.0				244.0		1.0
Other comprehensive income (loss)	$ 36.0			36.0
Issuance of common stock and stock options exercised (in shares)		1.4
Issuance of common stock and stock options exercised		$ 44.0
Share repurchase program (in shares)		(1.0)
Share repurchase program					(170.0)
Share-based compensation expenses		$ 29.0
Dividends declared					(121.0)
Balance at ending of period (in shares) at Apr. 03, 2021		170.6
Balance at end of period at Apr. 03, 2021		$ 834.0		(2,410.0)	1,080.0		18.0
Balance at beginning of period (in shares) at Dec. 31, 2020		170.2
Balance at beginning of period at Dec. 31, 2020		$ 761.0		(2,446.0)	1,127.0		17.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06
Balance at ending of period (in shares) at Dec. 31, 2021		169.6
Balance at end of period at Dec. 31, 2021	$ (23.0)	$ 989.0	$ (10.0)	(2,379.0)	1,350.0	$ 10.0	17.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	268.0				267.0		1.0
Other comprehensive income (loss)	$ (5.0)			(5.0)
Issuance of common stock and stock options exercised (in shares)		1.2
Issuance of common stock and stock options exercised		$ 50.0
Share repurchase program (in shares)	(2.2)	(2.2)
Share repurchase program	$ (493.0)				(493.0)
Share-based compensation expenses		$ 37.0
Dividends declared					(132.0)
Balance at ending of period (in shares) at Apr. 02, 2022		168.6
Balance at end of period at Apr. 02, 2022	$ (298.0)	$ 1,066.0		$ (2,384.0)	$ 1,002.0		$ 18.0